Bionano Genomics (NASDAQ:BNGO) Stock Rating Upgraded by Maxim Group
Bionano Genomics (NASDAQ:BNGO – Get Free Report) was upgraded by analysts at Maxim Group from a “hold” rating to a “buy” rating in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has a $8.00 price target on the stock. Maxim Group’s price objective would indicate a potential upside of 120.99% from the company’s […]
Bionano Genomics (NASDAQ:BNGO – Get Free Report) was upgraded by analysts at Maxim Group from a “hold” rating to a “buy” rating in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has a $8.00 price target on the stock. Maxim Group’s price objective would indicate a potential upside of 120.99% from the company’s […]
